12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, health care stocks saw significant movements. INVO Bioscience led the gainers with a 93.4% increase following their Q4 earnings release. Other notable gainers include Clene, Galera Therapeutics, Vanda Pharma, Chromocell Therapeutics, and BIMI Intl Medical. On the losing side, Sage Therapeutics saw the largest drop of 19.4%, followed by declines in Ontrak, China SXT Pharmaceuticals, Dynatronics, Etao International Co, and Precision BioSciences.
April 17, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ontrak stock declined 17.81% to $0.38 following their Q4 earnings release, with a market cap of $16.0 million.
Ontrak's decline is directly linked to its Q4 earnings announcement, indicating a negative investor response. This significant drop suggests that the earnings report did not meet market expectations, leading to a bearish outlook in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Sage Therapeutics stock fell 19.4% to $12.6, with a market cap of $757.3 million.
Sage Therapeutics' significant stock price decline is a critical event for investors, likely due to negative market reactions or potentially disappointing news not specified in the article. This sharp decrease suggests a strong short-term bearish sentiment among investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
INVO Bioscience shares surged 93.4% to $1.47 after announcing Q4 earnings, with a market cap of $3.8 million.
The significant surge in INVO Bioscience's stock price is directly attributed to the positive reception of their Q4 earnings report. Given the substantial percentage increase, this news is highly relevant and important to investors, indicating a strong short-term bullish sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100